FDA sees high vacancy rates for drug manufacturer inspectors

The Food and Drug Administration is having trouble retaining employees who inspect drug manufacturers. The vacancy rate for these FDA investigators nearly doubled between November 2021 and June 2024. The agency tells the Government Accountability Office that travel … pay … and work-life balance are contributing factors to turnover. Investigators can spend up to 75% of their work hours on travel. The FDA paused many inspections of drug manufacturing facilities height of the COVID-19 pandemic. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.